Market Cap 1.79B
Revenue (ttm) 1.54B
Net Income (ttm) 67.74M
EPS (ttm) N/A
PE Ratio 8.84
Forward PE 8.77
Profit Margin 4.39%
Debt to Equity Ratio 1.17
Volume 762,800
Avg Vol 699,108
Day's Range N/A - N/A
Shares Out 77.16M
Stochastic %K 94%
Beta 1.16
Analysts Hold
Price Target $26.00

Latest News on IART

Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results

Jul 30, 2024, 11:36 AM EDT - 6 months ago

Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results


Integra LifeSciences Announces Leadership Transition Plan

Feb 28, 2024, 6:00 AM EST - 11 months ago

Integra LifeSciences Announces Leadership Transition Plan